Litcius/Paper detail

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure

Michele Emdin, Alberto Aimo, Vincenzo Castiglione, Giuseppe Vergaro, Georgios Georgiopoulos, Luigi Francesco Saccaro, Carlo Lombardi, Claudio Passino, Elisabetta Cerbai, Marco Metra, Michele Senni

2020Journal of the American College of Cardiology101 citationsDOI

Topics & Concepts

Cyclic guanosine monophosphateMedicineHeart failureEjection fractionSacubitrilValsartanInternal medicineGuanosineNatriuretic peptideNeprilysinNitric oxideSacubitril, ValsartanGuanylate cyclasecGMP-specific phosphodiesterase type 5CardiologyAngiotensin IIPhosphodiesterasePharmacologyReceptorBiochemistryBlood pressureChemistrySildenafilEnzymeHeart Failure Treatment and ManagementPhosphodiesterase function and regulationNitric Oxide and Endothelin Effects
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure | Litcius